Page last updated: 2024-10-24

protein palmitoylation

Definition

Target type: biologicalprocess

The covalent attachment of a palmitoyl group to a protein. [GOC:jl, PMID:15520806]

Protein palmitoylation is a reversible post-translational modification that involves the attachment of palmitic acid, a 16-carbon saturated fatty acid, to cysteine residues within a protein. This modification plays a critical role in regulating a wide range of cellular processes, including protein trafficking, membrane association, signaling, and protein-protein interactions. The process is typically catalyzed by palmitoyl acyltransferases (PATs), a family of enzymes that transfer palmitate from a palmitoyl-CoA donor to the cysteine residue of the target protein. The reaction proceeds through a two-step mechanism: 1) the formation of a thioester bond between the palmitate and the active site cysteine of the PAT enzyme, followed by 2) the transfer of palmitate to the cysteine residue of the target protein. Palmitoylation can be reversed by palmitoyl protein thioesterases (PPTs), which hydrolyze the thioester bond between palmitate and the cysteine residue. The palmitoylation status of a protein is dynamic and can be regulated by a variety of factors, including cellular signaling pathways, protein phosphorylation, and the availability of palmitoyl-CoA. This dynamic regulation allows cells to fine-tune the localization, activity, and interactions of palmitoylated proteins in response to changing cellular conditions. Palmitoylation is crucial for the proper function of a wide range of proteins, including those involved in signal transduction, membrane trafficking, and cytoskeletal organization. For example, palmitoylation is essential for the localization and function of G protein-coupled receptors (GPCRs), a large family of cell surface receptors that play critical roles in regulating a variety of physiological processes. Palmitoylation of GPCRs facilitates their association with the plasma membrane, thereby enhancing their ability to interact with their signaling partners and activate downstream signaling pathways. Additionally, palmitoylation is involved in the regulation of ion channels, cytoskeletal proteins, and enzymes, underscoring its importance in diverse cellular processes.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Protein-serine O-palmitoleoyltransferase porcupineA protein-serine O-palmitoleoyltransferase porcupine that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H237]Homo sapiens (human)
Palmitoyltransferase ZDHHC2A palmitoyltransferase ZDHHC2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UIJ5]Homo sapiens (human)
Glutamine synthetaseA glutamine synthetase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P15104]Homo sapiens (human)

Compounds (5)

CompoundDefinitionClassesRoles
prednisoloneprednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
11beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone
adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
2-bromopalmitate2-bromohexadecanoic acid : A bromo fatty acid that is hexadecanoic (palmitic) acid carrying a single bromo substituent at position 2.

2-bromopalmitate: inhibitor of fatty acid oxidation; RN given refers to parent cpd
2-bromocarboxylic acid;
bromo fatty acid;
long-chain fatty acid;
straight-chain fatty acid
fatty acid oxidation inhibitor
N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)thio]acetamideorganic heterobicyclic compound;
organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
lgk974LGK974 : A carboxamide, the structure of which is that of acetamide substituted on carbon by a 2',3-dimethyl-2,4'-bipyridin-5-yl group and on nitrogen by a 5-(pyrazin-2-yl)pyridin-2-yl group. It is a highly potent, selective and orally bioavailable Porcupine inhibitor (a Wnt signalling inhibitor).

LGK974: a potent and specific small-molecule inhibitor of Porcupine (PORCN) acyltransferase
bipyridines;
pyrazines;
pyridines;
secondary carboxamide
Wnt signalling inhibitor
wnt-c592-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide: a PORCN acyltransferase inhibitor; structure in first source